Virpax Pharmaceuticals Statistics
Total Valuation
VRPX has a market cap or net worth of 272,001. The enterprise value is -1.24 million.
| Market Cap | 272,001 |
| Enterprise Value | -1.24M |
Important Dates
The next estimated earnings date is Monday, May 12, 2025.
| Earnings Date | May 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
VRPX has 1.06 million shares outstanding. The number of shares has increased by 263.24% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 1.06M |
| Shares Change (YoY) | +263.24% |
| Shares Change (QoQ) | +98.25% |
| Owned by Insiders (%) | 0.00% |
| Owned by Institutions (%) | 0.50% |
| Float | 1.05M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | -0.30 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 0.10 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.63
| Current Ratio | 0.63 |
| Quick Ratio | 0.61 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -116.43 |
Financial Efficiency
Return on equity (ROE) is -2,364.82% and return on invested capital (ROIC) is -1,479.57%.
| Return on Equity (ROE) | -2,364.82% |
| Return on Assets (ROA) | -135.01% |
| Return on Invested Capital (ROIC) | -1,479.57% |
| Return on Capital Employed (ROCE) | 1,322.00% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -6.03M |
| Employee Count | 2 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -99.71% in the last 52 weeks. The beta is 1.42, so VRPX's price volatility has been higher than the market average.
| Beta (5Y) | 1.42 |
| 52-Week Price Change | -99.71% |
| 50-Day Moving Average | 3.69 |
| 200-Day Moving Average | 14.00 |
| Relative Strength Index (RSI) | 14.73 |
| Average Volume (20 Days) | 430,256 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.79 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -12.08M |
| Pretax Income | -12.07M |
| Net Income | -12.07M |
| EBITDA | n/a |
| EBIT | -12.08M |
| Earnings Per Share (EPS) | -70.91 |
Balance Sheet
The company has 1.51 million in cash and n/a in debt, giving a net cash position of 1.51 million or 1.42 per share.
| Cash & Cash Equivalents | 1.51M |
| Total Debt | n/a |
| Net Cash | 1.51M |
| Net Cash Per Share | 1.42 |
| Equity (Book Value) | -913,760 |
| Book Value Per Share | -1.53 |
| Working Capital | -913,760 |
Cash Flow
| Operating Cash Flow | -16.71M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
VRPX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -263.24% |
| Shareholder Yield | -263.24% |
| Earnings Yield | -4,436.46% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on March 21, 2025. It was a reverse split with a ratio of 0.04.
| Last Split Date | Mar 21, 2025 |
| Split Type | Reverse |
| Split Ratio | 0.04 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |